Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.
Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.
JCAD’s coverage of the 2022 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).